Scienture Holdings Inc (SCNX) is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and absence of strong trading signals suggest holding off on investment until further clarity or improvement in fundamentals.
The MACD is positive and expanding, indicating a bullish momentum. RSI is in the neutral zone at 68.456, suggesting no overbought or oversold conditions. Moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 0.385, with resistance at 0.427 and support at 0.343.
Analyst coverage initiated with a Buy rating and a $1.50 price target, which is significantly higher than the current price.
No recent news or significant trading trends. Financial performance is weak, with revenue dropping to zero in Q4 2025 and a negative net income of -28.12M. Congress trading data shows no recent activity, and the stock has a 70% chance of a minor decline (-0.16%) in the next day.
In Q4 2025, revenue dropped to zero (-100% YoY). Net income improved to -28.12M (+292.59% YoY), but it remains negative. EPS increased to -1.51 (+106.85% YoY), and gross margin improved significantly to 76.8% (+1343.61% YoY). Despite some improvements, the company is still unprofitable.
Maxim initiated coverage on 2026-02-24 with a Buy rating and a $1.50 price target, indicating potential upside from the current price.